Surface Oncology shares are trading higher after Coherus Biosciences announced it will acquire the company.
Portfolio Pulse from Benzinga Newsdesk
Coherus Biosciences announced it will acquire Surface Oncology, causing Surface Oncology shares to trade higher.
June 16, 2023 | 1:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Surface Oncology shares are trading higher after Coherus Biosciences announced its acquisition.
The acquisition announcement by Coherus Biosciences has led to an increase in Surface Oncology's share price. Investors are likely to view this acquisition positively, as it may lead to potential growth and expansion for Surface Oncology.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Coherus Biosciences announced it will acquire Surface Oncology, which may impact its stock price.
Coherus Biosciences' announcement of acquiring Surface Oncology may have an impact on its stock price. The market's perception of the acquisition's potential benefits or risks will determine the direction of the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80